 | • レポートコード：MRC2-11QY06718 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胃抑制性ポリペプチド受容体のグローバル市場について調査・分析したレポートです。種類別（HM-15211、LBT-6030、LY-3298176、NNC-92041706、その他）市場規模、用途別（代謝障害、2型糖尿病、肥満、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胃抑制性ポリペプチド受容体の競争状況、市場シェア ・世界の胃抑制性ポリペプチド受容体市場：種類別市場規模 2015年-2020年（HM-15211、LBT-6030、LY-3298176、NNC-92041706、その他） ・世界の胃抑制性ポリペプチド受容体市場：種類別市場規模予測 2021年-2026年（HM-15211、LBT-6030、LY-3298176、NNC-92041706、その他） ・世界の胃抑制性ポリペプチド受容体市場：用途別市場規模 2015年-2020年（代謝障害、2型糖尿病、肥満、その他） ・世界の胃抑制性ポリペプチド受容体市場：用途別市場規模予測 2021年-2026年（代謝障害、2型糖尿病、肥満、その他） ・北米の胃抑制性ポリペプチド受容体市場分析：米国、カナダ ・ヨーロッパの胃抑制性ポリペプチド受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胃抑制性ポリペプチド受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胃抑制性ポリペプチド受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胃抑制性ポリペプチド受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alchemia Limited、AstraZeneca Plc、Carmot Therapeutics, Inc.、Diabetica Limited、Longevity Biotech, Inc、Novo Nordisk A/S、Sanofi、Zealand Pharma A/S ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Gastric Inhibitory Polypeptide Receptor Market
The global Gastric Inhibitory Polypeptide Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gastric Inhibitory Polypeptide Receptor Scope and Market Size
Gastric Inhibitory Polypeptide Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastric Inhibitory Polypeptide Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gastric Inhibitory Polypeptide Receptor market is segmented into
HM-15211
LBT-6030
LY-3298176
NNC-92041706
Others
Segment by Application, the Gastric Inhibitory Polypeptide Receptor market is segmented into
Metabolic Disorder
Type 2 Diabetes
Obesity
Others
Regional and Country-level Analysis
The Gastric Inhibitory Polypeptide Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gastric Inhibitory Polypeptide Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gastric Inhibitory Polypeptide Receptor Market Share Analysis
Gastric Inhibitory Polypeptide Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastric Inhibitory Polypeptide Receptor business, the date to enter into the Gastric Inhibitory Polypeptide Receptor market, Gastric Inhibitory Polypeptide Receptor product introduction, recent developments, etc.
The major vendors covered:
Alchemia Limited
AstraZeneca Plc
Carmot Therapeutics, Inc.
Diabetica Limited
Longevity Biotech, Inc
Novo Nordisk A/S
Sanofi
Zealand Pharma A/S
1 Study Coverage
1.1 Gastric Inhibitory Polypeptide Receptor Product Introduction
1.2 Market Segments
1.3 Key Gastric Inhibitory Polypeptide Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastric Inhibitory Polypeptide Receptor Market Size Growth Rate by Type
1.4.2 HM-15211
1.4.3 LBT-6030
1.4.4 LY-3298176
1.4.5 NNC-92041706
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gastric Inhibitory Polypeptide Receptor Market Size Growth Rate by Application
1.5.2 Metabolic Disorder
1.5.3 Type 2 Diabetes
1.5.4 Obesity
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastric Inhibitory Polypeptide Receptor Market Size, Estimates and Forecasts
2.1.1 Global Gastric Inhibitory Polypeptide Receptor Revenue 2015-2026
2.1.2 Global Gastric Inhibitory Polypeptide Receptor Sales 2015-2026
2.2 Global Gastric Inhibitory Polypeptide Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Gastric Inhibitory Polypeptide Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gastric Inhibitory Polypeptide Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gastric Inhibitory Polypeptide Receptor Competitor Landscape by Players
3.1 Gastric Inhibitory Polypeptide Receptor Sales by Manufacturers
3.1.1 Gastric Inhibitory Polypeptide Receptor Sales by Manufacturers (2015-2020)
3.1.2 Gastric Inhibitory Polypeptide Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Gastric Inhibitory Polypeptide Receptor Revenue by Manufacturers
3.2.1 Gastric Inhibitory Polypeptide Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Gastric Inhibitory Polypeptide Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastric Inhibitory Polypeptide Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastric Inhibitory Polypeptide Receptor Revenue in 2019
3.2.5 Global Gastric Inhibitory Polypeptide Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gastric Inhibitory Polypeptide Receptor Price by Manufacturers
3.4 Gastric Inhibitory Polypeptide Receptor Manufacturing Base Distribution, Product Types
3.4.1 Gastric Inhibitory Polypeptide Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastric Inhibitory Polypeptide Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Gastric Inhibitory Polypeptide Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastric Inhibitory Polypeptide Receptor Market Size by Type (2015-2020)
4.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020)
4.1.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Type (2015-2020)
4.1.3 Gastric Inhibitory Polypeptide Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Gastric Inhibitory Polypeptide Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastric Inhibitory Polypeptide Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastric Inhibitory Polypeptide Receptor Market Size by Application (2015-2020)
5.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020)
5.1.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Application (2015-2020)
5.1.3 Gastric Inhibitory Polypeptide Receptor Price by Application (2015-2020)
5.2 Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastric Inhibitory Polypeptide Receptor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Gastric Inhibitory Polypeptide Receptor by Country
6.1.1 North America Gastric Inhibitory Polypeptide Receptor Sales by Country
6.1.2 North America Gastric Inhibitory Polypeptide Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Type
6.3 North America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Application
7 Europe
7.1 Europe Gastric Inhibitory Polypeptide Receptor by Country
7.1.1 Europe Gastric Inhibitory Polypeptide Receptor Sales by Country
7.1.2 Europe Gastric Inhibitory Polypeptide Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Type
7.3 Europe Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Gastric Inhibitory Polypeptide Receptor by Region
8.1.1 Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Region
8.1.2 Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Type
8.3 Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Gastric Inhibitory Polypeptide Receptor by Country
9.1.1 Latin America Gastric Inhibitory Polypeptide Receptor Sales by Country
9.1.2 Latin America Gastric Inhibitory Polypeptide Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Type
9.3 Central & South America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Gastric Inhibitory Polypeptide Receptor by Country
10.1.1 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales by Country
10.1.2 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Application
11 Company Profiles
11.1 Alchemia Limited
11.1.1 Alchemia Limited Corporation Information
11.1.2 Alchemia Limited Description and Business Overview
11.1.3 Alchemia Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Products Offered
11.1.5 Alchemia Limited Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Carmot Therapeutics, Inc.
11.3.1 Carmot Therapeutics, Inc. Corporation Information
11.3.2 Carmot Therapeutics, Inc. Description and Business Overview
11.3.3 Carmot Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Products Offered
11.3.5 Carmot Therapeutics, Inc. Related Developments
11.4 Diabetica Limited
11.4.1 Diabetica Limited Corporation Information
11.4.2 Diabetica Limited Description and Business Overview
11.4.3 Diabetica Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Products Offered
11.4.5 Diabetica Limited Related Developments
11.5 Longevity Biotech, Inc
11.5.1 Longevity Biotech, Inc Corporation Information
11.5.2 Longevity Biotech, Inc Description and Business Overview
11.5.3 Longevity Biotech, Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Products Offered
11.5.5 Longevity Biotech, Inc Related Developments
11.6 Novo Nordisk A/S
11.6.1 Novo Nordisk A/S Corporation Information
11.6.2 Novo Nordisk A/S Description and Business Overview
11.6.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Products Offered
11.6.5 Novo Nordisk A/S Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Gastric Inhibitory Polypeptide Receptor Products Offered
11.7.5 Sanofi Related Developments
11.8 Zealand Pharma A/S
11.8.1 Zealand Pharma A/S Corporation Information
11.8.2 Zealand Pharma A/S Description and Business Overview
11.8.3 Zealand Pharma A/S Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Products Offered
11.8.5 Zealand Pharma A/S Related Developments
11.1 Alchemia Limited
11.1.1 Alchemia Limited Corporation Information
11.1.2 Alchemia Limited Description and Business Overview
11.1.3 Alchemia Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Products Offered
11.1.5 Alchemia Limited Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Gastric Inhibitory Polypeptide Receptor Market Estimates and Projections by Region
12.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Gastric Inhibitory Polypeptide Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Gastric Inhibitory Polypeptide Receptor Sales Forecast (2021-2026)
12.2.2 North America: Gastric Inhibitory Polypeptide Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Gastric Inhibitory Polypeptide Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Gastric Inhibitory Polypeptide Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Gastric Inhibitory Polypeptide Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gastric Inhibitory Polypeptide Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gastric Inhibitory Polypeptide Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Gastric Inhibitory Polypeptide Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Gastric Inhibitory Polypeptide Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Gastric Inhibitory Polypeptide Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gastric Inhibitory Polypeptide Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gastric Inhibitory Polypeptide Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gastric Inhibitory Polypeptide Receptor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gastric Inhibitory Polypeptide Receptor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastric Inhibitory Polypeptide Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Gastric Inhibitory Polypeptide Receptor Market Segments
Table 2. Ranking of Global Top Gastric Inhibitory Polypeptide Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastric Inhibitory Polypeptide Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of HM-15211
Table 5. Major Manufacturers of LBT-6030
Table 6. Major Manufacturers of LY-3298176
Table 7. Major Manufacturers of NNC-92041706
Table 8. Major Manufacturers of Others
Table 9. Global Gastric Inhibitory Polypeptide Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Gastric Inhibitory Polypeptide Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Gastric Inhibitory Polypeptide Receptor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Regions (2015-2020)
Table 13. Global Gastric Inhibitory Polypeptide Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Gastric Inhibitory Polypeptide Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Manufacturers (2015-2020)
Table 16. Global Gastric Inhibitory Polypeptide Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Gastric Inhibitory Polypeptide Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Inhibitory Polypeptide Receptor as of 2019)
Table 18. Gastric Inhibitory Polypeptide Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Gastric Inhibitory Polypeptide Receptor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Gastric Inhibitory Polypeptide Receptor Price (2015-2020) (USD/Pcs)
Table 21. Gastric Inhibitory Polypeptide Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gastric Inhibitory Polypeptide Receptor Product Type
Table 23. Date of International Manufacturers Enter into Gastric Inhibitory Polypeptide Receptor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Type (2015-2020)
Table 27. Global Gastric Inhibitory Polypeptide Receptor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Type (2015-2020)
Table 29. Gastric Inhibitory Polypeptide Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Application (2015-2020)
Table 32. North America Gastric Inhibitory Polypeptide Receptor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2015-2020)
Table 34. North America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2015-2020)
Table 36. North America Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2015-2020)
Table 38. North America Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2015-2020)
Table 40. Europe Gastric Inhibitory Polypeptide Receptor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2015-2020)
Table 42. Europe Gastric Inhibitory Polypeptide Receptor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2015-2020)
Table 44. Europe Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2015-2020)
Table 46. Europe Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2015-2020)
Table 56. Latin America Gastric Inhibitory Polypeptide Receptor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Gastric Inhibitory Polypeptide Receptor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2015-2020)
Table 62. Latin America Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2015-2020)
Table 72. Alchemia Limited Corporation Information
Table 73. Alchemia Limited Description and Major Businesses
Table 74. Alchemia Limited Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Alchemia Limited Product
Table 76. Alchemia Limited Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. Carmot Therapeutics, Inc. Corporation Information
Table 83. Carmot Therapeutics, Inc. Description and Major Businesses
Table 84. Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Carmot Therapeutics, Inc. Product
Table 86. Carmot Therapeutics, Inc. Recent Development
Table 87. Diabetica Limited Corporation Information
Table 88. Diabetica Limited Description and Major Businesses
Table 89. Diabetica Limited Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Diabetica Limited Product
Table 91. Diabetica Limited Recent Development
Table 92. Longevity Biotech, Inc Corporation Information
Table 93. Longevity Biotech, Inc Description and Major Businesses
Table 94. Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Longevity Biotech, Inc Product
Table 96. Longevity Biotech, Inc Recent Development
Table 97. Novo Nordisk A/S Corporation Information
Table 98. Novo Nordisk A/S Description and Major Businesses
Table 99. Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Novo Nordisk A/S Product
Table 101. Novo Nordisk A/S Recent Development
Table 102. Sanofi Corporation Information
Table 103. Sanofi Description and Major Businesses
Table 104. Sanofi Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Sanofi Product
Table 106. Sanofi Recent Development
Table 107. Zealand Pharma A/S Corporation Information
Table 108. Zealand Pharma A/S Description and Major Businesses
Table 109. Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Zealand Pharma A/S Product
Table 111. Zealand Pharma A/S Recent Development
Table 112. Global Gastric Inhibitory Polypeptide Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Gastric Inhibitory Polypeptide Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Gastric Inhibitory Polypeptide Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Gastric Inhibitory Polypeptide Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Gastric Inhibitory Polypeptide Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Gastric Inhibitory Polypeptide Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Gastric Inhibitory Polypeptide Receptor Players
Table 130. Gastric Inhibitory Polypeptide Receptor Customers List
Table 131. Gastric Inhibitory Polypeptide Receptor Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastric Inhibitory Polypeptide Receptor Product Picture
Figure 2. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. HM-15211 Product Picture
Figure 4. LBT-6030 Product Picture
Figure 5. LY-3298176 Product Picture
Figure 6. NNC-92041706 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020 & 2026
Figure 9. Metabolic Disorder
Figure 10. Type 2 Diabetes
Figure 11. Obesity
Figure 12. Others
Figure 13. Gastric Inhibitory Polypeptide Receptor Report Years Considered
Figure 14. Global Gastric Inhibitory Polypeptide Receptor Market Size 2015-2026 (US$ Million)
Figure 15. Global Gastric Inhibitory Polypeptide Receptor Sales 2015-2026 (K Pcs)
Figure 16. Global Gastric Inhibitory Polypeptide Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2015-2020)
Figure 18. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region in 2019
Figure 19. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region (2015-2020)
Figure 20. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region in 2019
Figure 21. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Gastric Inhibitory Polypeptide Receptor Revenue in 2019
Figure 23. Gastric Inhibitory Polypeptide Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2015-2020)
Figure 25. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2019
Figure 26. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Type (2015-2020)
Figure 27. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Type in 2019
Figure 28. Global Gastric Inhibitory Polypeptide Receptor Market Share by Price Range (2015-2020)
Figure 29. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2015-2020)
Figure 30. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2019
Figure 31. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Application (2015-2020)
Figure 32. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Application in 2019
Figure 33. North America Gastric Inhibitory Polypeptide Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country in 2019
Figure 36. North America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country in 2019
Figure 37. U.S. Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Gastric Inhibitory Polypeptide Receptor Market Share by Type in 2019
Figure 42. North America Gastric Inhibitory Polypeptide Receptor Market Share by Application in 2019
Figure 43. Europe Gastric Inhibitory Polypeptide Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country in 2019
Figure 46. Europe Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country in 2019
Figure 47. Germany Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Gastric Inhibitory Polypeptide Receptor Market Share by Type in 2019
Figure 58. Europe Gastric Inhibitory Polypeptide Receptor Market Share by Application in 2019
Figure 59. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region in 2019
Figure 62. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region in 2019
Figure 63. China Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Share by Type in 2019
Figure 86. Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Share by Application in 2019
Figure 87. Latin America Gastric Inhibitory Polypeptide Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country in 2019
Figure 90. Latin America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country in 2019
Figure 91. Mexico Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Gastric Inhibitory Polypeptide Receptor Market Share by Type in 2019
Figure 98. Latin America Gastric Inhibitory Polypeptide Receptor Market Share by Application in 2019
Figure 99. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country in 2019
Figure 103. Turkey Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Share by Type in 2019
Figure 110. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Share by Application in 2019
Figure 111. North America Gastric Inhibitory Polypeptide Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Gastric Inhibitory Polypeptide Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Gastric Inhibitory Polypeptide Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
オキシトシン受容体拮抗薬の世界市場（～2026年） Market Analysis and Insights: Global Oxytocin Receptor Antagonists Market The global Oxytocin Receptor Antagonists market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oxytocin Receptor Antagonists Scope and Market Size Oxy…- 膵島アミロイドポリペプチドの世界市場（～2026年） Market Analysis and Insights: Global Islet Amyloid Polypeptide Market The global Islet Amyloid Polypeptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Islet Amyloid Polypeptide Scope and Market Size Islet Amyloid P…
- 化学合成ポリペプチド薬の世界市場（～2026年） Chemosynthetic polypeptide drugs are composed of certain amino acids that combine to form a single unit. These drugs do produce a considerable remedial effect on different diseases, however, accompanied by a few side effects. Chemosynthetic polypeptide drugs are considered closely important mainly b…
- コラーゲンポリペプチドの世界市場（～2026年） Market Analysis and Insights: Global Collagen Polypeptide Market The global Collagen Polypeptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Collagen Polypeptide Scope and Market Size Collagen Polypeptide market is…
- ポリペプチド薬の世界市場（～2026年） Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.…